Evidence map›Paper›PMID 28528439›Full record

ReviewAdvances in anatomy, embryology, and cell biology2017

Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Evelyn A Kurt-Jones, Megan H Orzalli, David M Knipe

Open access · greenAbstract readReview
In one paragraph

Review in Advances in anatomy, embryology, and cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Nuclear interferon-stimulated gene product maintains heterochromatin on the herpes simplex viral genome to limit lytic infection.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Programmed Necrosis in Host Defense.Current topics in microbiology and immunology · 2023
    Article
  19. Review
  20. Abnormal glucose metabolism in virus associated sepsis.Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Evelyn A Kurt-JonesDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA. evelyn.kurt-jones@umassmed.edu.
Megan H OrzalliDivision of Gastroenterology, Boston Children's Hospital, Boston, MA, 02115, USA.
David M KnipeDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA. david_knipe@hms.harvard.edu.
Boston Children's Hospital · USHarvard University · USUniversity of Massachusetts Chan Medical School · US

Funding

VIral and host mechanisms that tilt the HSV lytic/latent balanceP01AI098681 · NIAID · HARVARD MEDICAL SCHOOL · PI PESOLA, JEAN M · 2013 to 2023
$19.2M
MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
MOLECULAR BASIS OF VIRAL INFECTIVITYT32AI007245 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Aaron Gregory Schmidt · 1985 to 2026
$11.3M
Nuclear Sensing of Herpesviral DNAR01AI106934 · NIAID · HARVARD MEDICAL SCHOOL · PI KNIPE, DAVID M. · 2014 to 2021
$3.8M
Epigenetic Regulation of HSV Infection of Oral CellsR56DE023909 · NIDCR · HARVARD MEDICAL SCHOOL · PI KNIPE, DAVID M. · 2013 to 2014
$822k
Nuclear Sensing of Herpesviral DNAR56AI106934 · NIAID · HARVARD MEDICAL SCHOOL · PI KNIPE, DAVID M. · 2024 to 2024
$587k
NIAID NIH HHS P01 AI098681NIAID NIH HHS R01 AI106934NIAID NIH HHS R56 AI106934NIAID NIH HHS T32 AI007245NIAID NIH HHS T32 AI007512NIDCR NIH HHS R56 DE023909
6 · The paper itself

Abstract

Innate immune responses play a major role in the control of herpes simplex virus (HSV) infections, and a multiplicity of mechanisms have emerged as a result of human evolution to sense and respond to HSV infections. HSV in turn has evolved a number of ways to evade immune detection and to blunt human innate immune responses. In this review, we summarize the major host innate immune mechanisms and the HSV evasion mechanisms that have evolved. We further discuss how disease can result if this equilibrium between virus and host response is disrupted.

Indexed as

Immunity, InnateAnimalsHerpes SimplexHerpesvirus 1, HumanHost-Pathogen InteractionsHumansImmune Evasion

Identifiers

PMID28528439
PMCPMC7254490
OpenAlexW2614551186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.